What is the recommended approach for rapid sequence induction in anesthesia for a patient with a full stomach or history of reflux who requires emergency surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rapid Sequence Induction in Anesthesia

Core Recommendation for Full Stomach/Reflux Patients

For patients with a full stomach or reflux requiring emergency surgery, perform rapid sequence induction using a fast-acting neuromuscular blocking agent (succinylcholine 1-2 mg/kg OR rocuronium 0.9-1.2 mg/kg) combined with a sedative-hypnotic agent, with pre-induction nasogastric decompression when feasible, head-up positioning, and immediate availability of backup airway equipment. 1, 2, 3, 4

Pre-Induction Risk Mitigation

Gastric Decompression

  • Insert a large-bore nasogastric tube before induction to decompress the stomach and remove gastric contents in high-risk patients such as those with bowel obstruction or significant gastric distension 2
  • Point-of-care gastric ultrasound can assess gastric volume and guide risk stratification, as 6-16% of appropriately fasted patients still have gastric content associated with aspiration risk 1
  • Whether to leave the gastric tube in place or remove it before induction remains controversial; if left in place, keep the proximal end open to atmosphere to act as a pressure valve 1

Patient Positioning

  • Use semi-Fowler position (head and torso elevated 20-30 degrees) during RSI to reduce aspiration risk and improve first-pass intubation success 2

Pharmacologic Management

Induction Agents

  • For hemodynamically unstable patients: use etomidate 0.3 mg/kg or ketamine 1-2 mg/kg 2, 4
  • For hemodynamically stable patients: propofol is acceptable 3, 4
  • Etomidate provides minimal cardiovascular depression and is preferred in unstable patients 4

Neuromuscular Blocking Agents (Critical Component)

  • A neuromuscular blocking agent MUST be administered when a sedative-hypnotic induction agent is used (strong recommendation from the Society of Critical Care Medicine) 1, 4
  • Use succinylcholine 1-2 mg/kg OR rocuronium 0.9-1.2 mg/kg for rapid onset and excellent intubation conditions 2, 3, 4, 5
  • Rocuronium 0.6-1.2 mg/kg provides intubating conditions in median 1 minute with excellent or good conditions in most patients within 2 minutes 5
  • Have sugammadex immediately available when using rocuronium for reversal in "cannot intubate/cannot oxygenate" scenarios 4

Timing and Administration

  • Administer sedative-hypnotic and NMBA in rapid succession with immediate endotracheal tube placement before assisted ventilation to minimize aspiration risk 4

Cricoid Pressure: The Evolving Controversy

Current Evidence

  • The role of cricoid pressure is highly controversial and no longer universally recommended 1, 3
  • French pediatric guidelines suggest NOT performing cricoid pressure during RSI to decrease respiratory complications, as systematic reviews show no scientific evidence supporting its efficacy in preventing aspiration 1
  • In vivo imaging demonstrates cricoid pressure produces lateral esophageal displacement and compresses the hypopharynx rather than protecting against aspiration 1

If Cricoid Pressure Is Applied

  • Apply initial force of 10 N when patient is awake, increasing to 30 N as consciousness is lost 2
  • If direct laryngoscopy proves difficult, release cricoid pressure immediately 2, 3
  • Cricoid pressure may make intubation more difficult and does not reliably prevent aspiration 2

Modified RSI Approach (When Appropriate)

Controlled/Modified RSI

  • A "controlled" or "modified" RSI approach includes gentle bag-mask ventilation with peak inspiratory pressure <15 cmH₂O if SpO₂ drops below 95% to prevent life-threatening hypoxemia 1, 3
  • This approach has shown decreased hypoxemia, hemodynamic complications, and difficult intubation with no observed aspiration events in retrospective studies 1
  • The risk of hypoxemia during classic RSI may exceed the risk of aspiration with controlled ventilation in many clinical scenarios 1

Critical Safety Considerations

Equipment Preparedness

  • Have video laryngoscopy, supraglottic airways, and surgical airway equipment immediately available 2
  • If intubation fails after maximum three attempts, immediately move to failed intubation plan 2

Special Populations

  • Dose obese patients based on actual body weight, not ideal body weight, as IBW dosing results in longer time to block and inadequate intubating conditions 5
  • Rocuronium is NOT recommended for rapid sequence induction in Cesarean section patients due to inadequate intubating conditions in studies using lower thiopental doses 5
  • Geriatric patients (65-80 years) achieve excellent intubating conditions with 0.6 mg/kg rocuronium in median 2.3 minutes without prolonged recovery 5

Additional Aspiration Risk Reduction Strategies

Beyond RSI itself, implement these interventions 1:

  • Administration of prokinetics (erythromycin 3 mg/kg 1-2 hours before induction) when time permits
  • Select tracheal tube rather than supraglottic airway device
  • Consider orogastric/nasogastric tube placement before induction and extubation

Critical Pitfalls to Avoid

  • Do NOT use inadequate NMBA doses: full RSI doses are succinylcholine 1-2 mg/kg or rocuronium 0.9-1.2 mg/kg 2, 4, 5
  • Do NOT delay emergency surgery excessively for optimization in true surgical emergencies like high-grade bowel obstruction 2
  • Do NOT persist with cricoid pressure if it impairs laryngoscopy 2, 3
  • Do NOT avoid gentle ventilation if hypoxemia develops during induction, as the risk-benefit calculation favors preventing critical hypoxemia 1
  • Recognize that RSI carries its own risks including difficult/failed intubation, esophageal intubation, anaphylaxis, awareness, and airway trauma 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Risk of Aspiration During Rapid Sequence Induction for High-Grade Small Bowel Obstruction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Induction and Intubation in Anesthesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Intubation Pharmacology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can unresponsive patients be intubated without Rapid Sequence Intubation (RSI) drugs?
What is the timing of the vomiting reflex during rapid sequence induction of anesthesia?
What is the duration of regurgitation during anesthesia induction in patients undergoing rapid sequence intubation?
What is the evidence for rapid sequence induction (RSI) in preventing aspiration in high-risk patients?
Is aspiration during rapid sequence induction (RSI) of anesthesia an indication of malpractice?
How do I safely switch a healthy infant from an organic infant formula to a standard, non-organic formula?
What is the best course of action for a child with autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), depression, anxiety, oppositional defiant disorder, exercise-induced asthma, and perioral dermatitis, currently taking methylphenidate, fluoxetine, cetirizine, fluticasone propionate, and albuterol sulfate, who presents with a nasty cough, chest congestion, low-grade fever, runny nose, and mild hoarseness?
What is the diagnosis for a pediatric patient with pneumonia, who develops respiratory distress 5 days after starting treatment, with bilateral basal crackles, hypercapnia (elevated CO2 level), and normal oxygen levels on Venous Blood Gas (VBG)?
What is the recommended dosage of isosorbide mononitrate for a patient with cardiovascular disease, specifically hypertension or heart failure?
What is the most appropriate management for a patient with lymphoma receiving B-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy who presents with hyperkalemia and hypocalcemia?
What causes a drop in hemoglobin levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.